iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy

iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy

Cell types differentiated from induced pluripotent stem cells (iPSCs) are frequently arrested in their development program, more closely resembling a fetal rather than an adult phenotype, potentially limiting their utility for downstream clinical applications. The fetal phenotype of iPSC‐derived den...

Полное описание

Библиографические подробности
Главные авторы:	Horton, C, Davies, TJ, Lahiri, P, Sachamitr, P, Fairchild, PJ
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley 2019

Схожие документы

Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
по: Sachamitr, P, и др.
Опубликовано: (2012)

Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy
по: Bravo, M, и др.
Опубликовано: (2021)

Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
по: Sachamitr, P, и др.
Опубликовано: (2018)

Enhancement of tolerogenic or immunostimulatory potential of dendritic cells for therapeutic goals
по: Hanif, Javanmard Khameneh
Опубликовано: (2011)

Enhancement of tolerogenic or immunostimulatory potential of dendritic cells for therapeutic goals.
по: Hanif Javanmard Khameneh
Опубликовано: (2014)

Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
по: Patty Sachamitr, и др.
Опубликовано: (2018-01-01)

Harnessing the properties of dendritic cells in the pursuit of immunological tolerance
по: Horton, C, и др.
Опубликовано: (2017)

Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration
по: Min-Seon Song, и др.
Опубликовано: (2024-01-01)

Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
по: Sachamitr, P, и др.
Опубликовано: (2014)

Immunostimulatory Potential of MoS2 Nanosheets: Enhancing Dendritic Cell Maturation, Migration and T Cell Elicitation
по: Deng L, и др.
Опубликовано: (2020-04-01)

Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
по: Joanna R. Wares, и др.
Опубликовано: (2015-07-01)

Dryocrassin Suppresses Immunostimulatory Function of Dendritic Cells and Prolongs Skin Allograft Survival
по: Ru-Huei Fu Ph. D., и др.
Опубликовано: (2014-05-01)

Correction: Telomere Reprogramming and Maintenance in Porcine iPS Cells
Опубликовано: (2013-01-01)

Pramef12 enhances reprogramming into naïve iPS cells
по: Daiki Haraguchi, и др.
Опубликовано: (2022-07-01)

Correction: Telomere Reprogramming and Maintenance in Porcine iPS Cells.
по: Guangzhen Ji, и др.
Опубликовано: (2013-01-01)

Dendritic Cells and Their Role in Immunotherapy
по: Alycia Gardner, и др.
Опубликовано: (2020-05-01)

Thymic dendritic cells: phenotype and function.
по: Fairchild, P, и др.
Опубликовано: (1990)

Dendritic cells and prospects for transplantation tolerance.
по: Fairchild, P, и др.
Опубликовано: (2000)

Harnessing the properties of dendritic cells in the pursuit of immunological tolerance
по: Christopher Horton, и др.
Опубликовано: (2017-04-01)

Differentiation of Human Induced Pluripotent Stem Cells (iPS Cells) and Embryonic Stem Cells (ES Cells) into Dendritic Cell (DC) Subsets
по: Stephanie Sontag, и др.
Опубликовано: (2017-08-01)

<it>In vivo </it>trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine
по: Shankar Nathan, и др.
Опубликовано: (2010-12-01)

Harnessing dendritic cells for the induction of transplantation tolerance.
по: Silk, K, и др.
Опубликовано: (2009)

Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
по: Dilip Dey, и др.
Опубликовано: (2011-01-01)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
по: Chunmei Fu, и др.
Опубликовано: (2022-01-01)

Melanoma immunotherapy: dendritic cell vaccines
по: Ivan Lozada-Requena, и др.
Опубликовано: (2015-09-01)

Immunotherapy with iPSC-derived dendritic cells brings a new perspective to an old debate: Autologous versus allogeneic?
по: Fairchild, P
Опубликовано: (2019)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
по: Hanka Jähnisch, и др.
Опубликовано: (2010-01-01)

Lactic Acid Bacteria Strains Exert Immunostimulatory Effect on H. pylori-Induced Dendritic Cells
по: Małgorzata Wiese, и др.
Опубликовано: (2015-01-01)

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
по: Berneman Zwi N, и др.
Опубликовано: (2009-12-01)

Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells
по: Oscar Badillo, и др.
Опубликовано: (2024-04-01)

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
по: João Calmeiro, и др.
Опубликовано: (2020-02-01)

Probing dendritic cell function by guiding the differentiation of embryonic stem cells.
по: Fairchild, P, и др.
Опубликовано: (2003)

Dendritic cell immunobiology and potential roles in immunotherapy
по: Fadilah, S.A.W., и др.
Опубликовано: (2007)

Cytokine-overexpressing dendritic cells for cancer immunotherapy
по: Joonsu Han, и др.
Опубликовано: (2024-12-01)

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
по: Jie Chen, и др.
Опубликовано: (2024-09-01)

DNA sensing of dendritic cells in cancer immunotherapy
по: Wei Qian, и др.
Опубликовано: (2024-05-01)

Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
по: Shumin Luo, и др.
Опубликовано: (2023-08-01)

Dendritic Cell-Based Immunotherapy in Lung Cancer
по: Dieter Stevens, и др.
Опубликовано: (2021-02-01)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
по: Xin Peng, и др.
Опубликовано: (2021-02-01)

Regulatory dendritic cells for immunotherapy in immunologic diseases
по: John Robert Gordon, и др.
Опубликовано: (2014-01-01)